These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3567077)

  • 21. [Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine].
    Michel B; Guillot B; Guilhou JJ; Meynadier J
    Ann Dermatol Venereol; 1983; 110(4):361-3. PubMed ID: 6625460
    [No Abstract]   [Full Text] [Related]  

  • 22. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary porphyrin excretion in various types of porphyria. Thin-layer chromatographic study.
    Perrot H; Boucherat M; Gardella C
    Dermatologica; 1980; 161(3):167-78. PubMed ID: 7398995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porphyria cutanea tarda symptomatica in children treated with chloroquine. Report of four cases with control liver biopsies.
    Tamayo L; Ruiz-Maldonado R; Ridaura C
    J Dermatol; 1985 Aug; 12(4):329-40. PubMed ID: 3910689
    [No Abstract]   [Full Text] [Related]  

  • 25. Photosensitivity after treatment of porphyria cutanea tarda with low dose chloroquine.
    Gould P
    Br J Dermatol; 1978 Feb; 98(2):225-8. PubMed ID: 629877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload.
    Valls V; Ena J; Enríquez-De-Salamanca R
    J Dermatol Sci; 1994 Jun; 7(3):169-75. PubMed ID: 7918235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation of (4-14 C) -aminolaevulinate into urinary porphyrins in porphyria cutanea tarda: effect of chloroquine therapy.
    Taljaard JJ; Shanley BC; Joubert SM; Deppe WM
    Clin Sci; 1973 Jun; 44(6):571-81. PubMed ID: 4713665
    [No Abstract]   [Full Text] [Related]  

  • 28. [Porphyria erythropoietica congenita Günther and chloroquine (author's transl)].
    Ippen H; Tillmann W; Seubert S; Seubert A
    Klin Wochenschr; 1978 Jun; 56(12):623-4. PubMed ID: 682527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Holvay E
    Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240
    [No Abstract]   [Full Text] [Related]  

  • 30. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyria variegata: failure of chloroquin treatment.
    Cramers M; Jepsen LV
    Acta Derm Venereol; 1980; 60(1):89-91. PubMed ID: 6153849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of D-glucaric acid in porphyria cutanea tarda.
    Tutor JC; Lopez-Urrutia A; Fernandez MP
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):855-8. PubMed ID: 2895161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin morphology in porphyria cutanea tarda does not improve despite clinical remission.
    Timonen K; Niemi KM; Mustajoki P
    Clin Exp Dermatol; 1991 Sep; 16(5):355-8. PubMed ID: 1794189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of porphyria cutanea tarda.
    Malina L
    Br J Dermatol; 1987 Jan; 116(1):139-40. PubMed ID: 3814510
    [No Abstract]   [Full Text] [Related]  

  • 35. [Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda].
    Drasch G; Eisenmenger W
    Z Rechtsmed; 1986; 97(4):285-93. PubMed ID: 3577436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of porphyria cutanea tarda with chloroquine.
    Kordac V; Semrádová M
    Br J Dermatol; 1974 Jan; 90(1):95-100. PubMed ID: 4811840
    [No Abstract]   [Full Text] [Related]  

  • 37. Porphyria cutanea tarda in three generations of a single family.
    Benedetto AV; Kushner JP; Taylor JS
    N Engl J Med; 1978 Feb; 298(7):358-62. PubMed ID: 622106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver changes in porphyria cutanea tarda patients treated with chloroquine.
    Chlumska A; Chlumsky J; Malina L
    Br J Dermatol; 1980 Mar; 102(3):261-6. PubMed ID: 7370174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Riedel H; Kemmer C
    Hautarzt; 1986 Apr; 37(4):210-6. PubMed ID: 3009356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary porphyrin analyses in patients with porphyria cutanea tarda.
    Nonaka S; Ogami T; Yoshida K; Honda T; Murayama F; Yoshida H
    J Dermatol; 1982 Oct; 9(5):397-404. PubMed ID: 6761381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.